Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
Bipolar disorder is a chronic and remitting mental illness. Antidepressants are not effective in treating acute bipolar depression, and antipsychotic drugs used in the treatment of bipolar depression cause frequent side effects. This situation justifies the search for new drugs as well as the repurp...
Main Authors: | Marek Krzystanek, Artur Pałasz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/10/326 |
Similar Items
-
Amantadine in Treatment of Dysthymia—The Pilot Case Series Study
by: Marek Krzystanek, et al.
Published: (2023-06-01) -
Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
by: Marek Krzystanek, et al.
Published: (2021-05-01) -
Treatment-resistant bipolar depression: concepts and challenges for novel interventions
by: Alexandre P. Diaz, et al.
Published: (2021-05-01) -
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
by: Marek Krzystanek, et al.
Published: (2021-09-01) -
Differences between Depression Episodes of Bipolar Disorder I and II
by: Leman Inanc, et al.
Published: (2013-09-01)